Statin therapy recommended for all patients with diabetes, regardless of cholesterol levels.
Read More »Issue 163 Item 10 Bacteria Could Help Failing Kidneys
Microbes groomed to breakdown toxic waste between dialysis sessions.
Read More »Issue 162 Item 11 A Population Perspective on Diabetes Prevention: Who Do We Tar
Preventing the entire population from gaining, on average, 1 BMI unit would result in a reduction in incidence of type 2 diabetes 13.0%.
Read More »Issue 163 Item 12 Lifestyle Intervention Reduced the Incidence of Diabetes by 58
The diabetes prevention program and its global implications.
Read More »Issue 163 Item 13 Nurse Practitioner-Run Specialty Clinic May Prove Effective in
Nurse practitioner (NP) specialty clinics for the management of patients with Type 2 diabetes appear to be an effective way to ensure high quality care of the growing number of people with the disease.
Read More »Issue 163 Item 14 Glargine In Morning or Evening?
New study shows less nocturnal lows and better control in Type 2’s who take in morning.
Read More »Issue 163 Item 15 Pre-Diabetic Condition More Common in Obese Girls
Obese girls are more likely to suffer from a pre-diabetic condition than their male counterparts, putting them at higher risk of adult-onset type 2 diabetes.
Read More »Polypill Proposed for All Older Persons to Prevent Cardiovascular Events
Issue 162 Item 1 A combination pill targeted at four risk factors for cardiovascular disease (CVD) would dramatically reduce heart attacks and strokes by 80 percent if administered to everyone 55 or older or with known occlusive vascular disease. The polypill, as the scientists called it in the British medical …
Read More »Issue 162 Item 2 Breathing Disorder Sleep Apnoea ‘Linked To Diabetes’
People with a common breathing disorder which strikes while they are asleep could be at increased risk of getting diabetes later in life.
Read More »Issue 162 Item 3 FDA Clears Bristol-Myers to Co-Package Statin With Aspirin Call
Bristol-Myers Squibb Company announced on Thursday that it received approval from the U.S. Food and Drug Administration (FDA) to market Pravachol (pravastatin) in combination with low-dose aspirin under a new brand name, Pravigard PAC
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.